Why is Zenith falling/rising?

As of 02-Jul, Zenith Drugs Ltd is experiencing a decline in its stock price, currently at 73.20, which reflects a decrease of 1.75 or 2.33%. The stock has underperformed its sector by 2.41% today, despite showing a higher delivery volume of 32.8k, which has risen by 28.13% against the 5-day average. In terms of returns, the stock has increased by 5.40% over the past week and 1.39% over the past month, but it has a year-to-date decline of 9.41%. Additionally, while the stock is above its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages, indicating a mixed performance trend. There are no positive or negative factors provided that could further clarify the reasons behind the stock's recent movement.
In the broader market context, Zenith's short-term performance has outpaced the benchmark Sensex over the past week, which has only increased by 0.83%. However, over the longer term, the stock has underperformed significantly year-to-date compared to the Sensex, which has gained 7.65%. This disparity suggests that while there may be some short-term investor interest, the overall sentiment towards Zenith Drugs Ltd remains cautious, contributing to its current price decline.